Insiders · Profile

Combs Andrew

Chief Chemistry Officer at Prelude Therapeutics. Filing since 29 Sep 2020. CIK 0001825005

Company

Date

Role

Action

Amount

Of holding

PRLD Prelude Therapeutics Inc

25 Mar 2025

Chief Chemistry Officer

Bought

100,000

$69.25K

26.3%

PRLD Prelude Therapeutics Inc

23 Dec 2024

Chief Chemistry Officer

Bought

60,000

$82.00K

18.9%

PRLD Prelude Therapeutics Inc

20 Dec 2024

Chief Chemistry Officer

Bought

3,075

$3.54K

1.0%

PRLD Prelude Therapeutics Inc

14 Dec 2021

EVP, Head of Chemistry

Bought

4,000

$46.40K

1.5%

PRLD Prelude Therapeutics Inc

13 Dec 2021

EVP, Head of Chemistry

Bought

4,000

$48.48K

1.5%

PRLD Prelude Therapeutics Inc

29 Sep 2020

EVP, Head of Chemistry

Bought

1,000

$19.00K

0.4%

6 decisions on file.